CHE (STOCKS)
Chemed Corporation
$462.890000
+10.890000 (+2.41%)
Prev close: $452.000000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Hospital/Nursing Management
- CEO
- Kevin J. McNamara
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,617.79M
- Employees
- 15,695
- P/E (TTM)
- 24.47
- P/B (TTM)
- 6.07
- Dividend Yield
- 47.53%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$5.27 | $5.43 | -0.1562 | -2.88% |
|
Jun 2025 (Q2)
|
$4.27 | $5.03 | -0.7598 | -15.11% |
|
Mar 2025 (Q1)
|
$5.63 | $5.60 | +0.0279 | +0.50% |
|
Dec 2024 (Q4)
|
$6.83 | $6.85 | -0.0212 | -0.31% |
Financial Statements
| Revenues | $2.53B |
| Benefits Costs and Expenses | $2.16B |
| Cost Of Revenue | $1.70B |
| Costs And Expenses | $2.18B |
| Gross Profit | $832.13M |
| Nonoperating Income/Loss | $20.71M |
| Operating Expenses | $2.18B |
| Selling, General, and Administrative Expenses | $415.94M |
| Other Operating Expenses | $1.76B |
| Operating Income/Loss | $351.47M |
| Income/Loss From Continuing Operations After Tax | $278.81M |
| Income/Loss From Continuing Operations Before Tax | $370.46M |
| Income Tax Expense/Benefit | $91.65M |
| Income Tax Expense/Benefit, Deferred | -$18.15M |
| Interest Expense, Operating | $1.73M |
| Net Income/Loss | $278.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $278.81M |
| Net Income/Loss Available To Common Stockholders, Basic | $278.81M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $19.03 |
| Diluted Earnings Per Share | $18.90 |
| Basic Average Shares | 14,477,000 |
| Diluted Average Shares | 14,553,000 |
| Common Stock Dividends | $2.10 |
| Assets | $1.62B |
| Current Assets | $395.24M |
| Inventory | $8.24M |
| Other Current Assets | $387.01M |
| Noncurrent Assets | $1.23B |
| Fixed Assets | $203.94M |
| Intangible Assets | $84.93M |
| Other Non-current Assets | $939.51M |
| Liabilities | $546.94M |
| Current Liabilities | $292.04M |
| Accounts Payable | $48.10M |
| Wages | $79.67M |
| Other Current Liabilities | $164.28M |
| Noncurrent Liabilities | $254.90M |
| Equity | $1.08B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.08B |
| Liabilities And Equity | $1.62B |
| Net Cash Flow From Operating Activities | $419.65M |
| Net Cash Flow From Operating Activities, Continuing | $419.65M |
| Net Cash Flow From Investing Activities | -$55.91M |
| Net Cash Flow From Investing Activities, Continuing | -$55.91M |
| Net Cash Flow From Financing Activities | -$472.44M |
| Net Cash Flow From Financing Activities, Continuing | -$472.44M |
| Net Cash Flow | -$108.70M |
| Net Cash Flow, Continuing | -$108.70M |
| Comprehensive Income/Loss | $278.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $278.81M |
| Other Comprehensive Income/Loss | $0.00 |